The use of AI/ML technology significantly enhances early cancer detection, diagnostic accuracy, and patient outcomes by accelerating Time-to-Treatment Initiation (TTI). Providers in underserved areas face barriers to adopt novel cancer care technologies due to high costs and tech-complexity, resulting in access inequities. We removed these barriers by offering MedTech Value-Added Solution (mtVAS) Platform-as-a-Service (PaaS). The mtVAS-PaaS equips our users with AI/ML-driven tools to detect cancer early and personalize treatment, achieving optimal outcomes.
| Website | https://histofi.com |
| Employees | 3 (2 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Hospitals and Health Care, Business Services General, Business Services |
| Keywords | Cancer Diagnostics, Early Cancer Detection, Cancer Treatment, Cancer Care, Cancer Detection Technology, Precision Oncology, Oncology Technology, Diagnostic Imaging, Patient Outcomes, Medical Technology, Pathology, Ai Healthcare, Healthcare Technology, Biotechnology, Digital Health, Healthtech |
| Competitors | Mayo Clinic Laboratories, Labcorp, Quest Diagnostics, Myriad Genetics, Invitae, ARUP Laboratories, PathGroup, Fulgent Genetics, Genomic Health, Sonic Healthcare +46 more (view full list) |
| SIC | SIC Code 806 Companies, SIC Code 80 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 622310 Companies, NAICS Code 62231 Companies, NAICS Code 6223 Companies, NAICS Code 622 Companies |
Looking for a particular Histofi, Inc. employee's phone or email?
Zakir Sikder is the CEO of Histofi, Inc..
2 people are employed at Histofi, Inc..
Histofi, Inc. is based in Los Angeles, California.
The NAICS codes for Histofi, Inc. are [62, 622310, 62231, 6223, 622].
The SIC codes for Histofi, Inc. are [806, 80].